148 related articles for article (PubMed ID: 38434653)
21. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice.
Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS
BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067
[TBL] [Abstract][Full Text] [Related]
22. Limosilactobacillus reuteri ameliorates preeclampsia in mice via improving gut dysbiosis and endothelial dysfunction.
Li B; Shi Y; Qiu W; Lin Q; Zeng S; Hou Y; Zhou H; Chen M; Zhang D
Biomed Pharmacother; 2023 May; 161():114429. PubMed ID: 36841030
[TBL] [Abstract][Full Text] [Related]
23. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
24. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Söderling EM; Marttinen AM; Haukioja AL
Curr Microbiol; 2011 Feb; 62(2):618-22. PubMed ID: 20835828
[TBL] [Abstract][Full Text] [Related]
25. Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin.
Khmaladze I; Butler É; Fabre S; Gillbro JM
Exp Dermatol; 2019 Jul; 28(7):822-828. PubMed ID: 31021014
[TBL] [Abstract][Full Text] [Related]
26. Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption.
Schepper JD; Collins FL; Rios-Arce ND; Raehtz S; Schaefer L; Gardinier JD; Britton RA; Parameswaran N; McCabe LR
J Bone Miner Res; 2019 Apr; 34(4):681-698. PubMed ID: 30690795
[TBL] [Abstract][Full Text] [Related]
27. Use of
Dargenio VN; Cristofori F; Dargenio C; Giordano P; Indrio F; Celano G; Francavilla R
Benef Microbes; 2022 Aug; 13(3):221-242. PubMed ID: 35212258
[TBL] [Abstract][Full Text] [Related]
28. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
29. Probiotic and Functional Properties of
Diez-Echave P; Martín-Cabrejas I; Garrido-Mesa J; Langa S; Vezza T; Landete JM; Hidalgo-García L; Algieri F; Mayer MJ; Narbad A; García-Lafuente A; Medina M; Rodríguez-Nogales A; Rodríguez-Cabezas ME; Gálvez J; Arqués JL
Nutrients; 2021 May; 13(6):. PubMed ID: 34072532
[No Abstract] [Full Text] [Related]
30. [Effect of oral
Liu Y; Huang Y; Cai W; Li D; Zheng W; Xiao Y; Liu Y; Zhao H; Pan S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1753-1759. PubMed ID: 33380389
[TBL] [Abstract][Full Text] [Related]
31. Early Colonization of Lactobacillus reuteri after Exposure to Probiotics.
Çaglar E; Topcuoglu N; Ozbey H; Sandalli N; Kulekci G
J Clin Pediatr Dent; 2015; 39(4):326-30. PubMed ID: 26161603
[TBL] [Abstract][Full Text] [Related]
32. Comparison between Antimicrobial and Antibiofilm Activity of Exopolysaccharides (EPS) Extracted from
Abed SM; Jabar Jasim H; Mijbas Mohammed Alomari M; Hamoodi Hussein G
Arch Razi Inst; 2022 Dec; 77(6):2215-2221. PubMed ID: 37274871
[TBL] [Abstract][Full Text] [Related]
33. Effect of Limosilactobacillus reuteri ZJF036 on Growth Performance and Gut Microbiota in Juvenile Beagle Dogs.
Zhao D; Zhang R; Wang J; Zhang X; Liu K; Zhang H; Liu H
Curr Microbiol; 2023 Mar; 80(5):155. PubMed ID: 36995478
[TBL] [Abstract][Full Text] [Related]
34. Effect of Oral Probiotic
Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
[TBL] [Abstract][Full Text] [Related]
35. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
36. Galacto-oligosaccharide preconditioning improves metabolic activity and engraftment of Limosilactobacillus reuteri and stimulates osteoblastogenesis ex vivo.
De Bruyn F; Bonnet N; Baruchet M; Sabatier M; Breton I; Bourqui B; Jankovic I; Horcajada MN; Prioult G
Sci Rep; 2024 Feb; 14(1):4329. PubMed ID: 38383774
[TBL] [Abstract][Full Text] [Related]
37.
Hu MX; He F; Guo YX; Mo LZ; Zhu X
J Agric Food Chem; 2022 Sep; 70(38):11935-11943. PubMed ID: 36111836
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.
Ang LY; Too HK; Tan EL; Chow TK; Shek LP; Tham EH; Alonso S
Virol J; 2016 Jun; 13():111. PubMed ID: 27341804
[TBL] [Abstract][Full Text] [Related]
39. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.
Jones SE; Versalovic J
BMC Microbiol; 2009 Feb; 9():35. PubMed ID: 19210794
[TBL] [Abstract][Full Text] [Related]
40. Influence of Lactobacillus reuteri, Bifidobacterium animalis subsp. lactis, and prebiotic inulin on dysbiotic dental biofilm composition ex vivo.
Colamarino AN; Johnson TM; Boudreaux DM; Dutner JM; Stancoven BW; Lincicum AR; Akers JA
J Periodontol; 2023 Jun; 94(6):793-804. PubMed ID: 36542391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
